Literature DB >> 1632344

Duodenal neoplasms: predictive value of CT for determining malignancy and tumor resectability.

E A Kazerooni1, L E Quint, I R Francis.   

Abstract

CT examinations of 25 patients with proved primary or metastatic duodenal neoplasms were retrospectively reviewed to determine if morphologic features seen on CT scans could be used to predict the benign or malignant nature of these neoplasms and to assess the effectiveness of using CT findings to predict tumor resectability. We studied 19 malignant and six benign tumors. Histologic proof was obtained by means of surgery in 20 patients and by endoscopic biopsy in five. CT features of tumor morphology were assessed in the 22 cases in which a duodenal tumor was seen on CT. These features included central necrosis, ulceration or excavation, and the location of the tumor with respect to the bowel wall. The specific morphologic features used to predict that a tumor was malignant included the presence of an exophytic or intramural mass, central necrosis, and ulceration. The only criterion used to predict that a tumor was benign was that the mass be entirely intraluminal. Whenever vascular encasement, invasion of contiguous organs other than the head of the pancreas, distant lymphadenopathy, or metastases were present, the tumor was predicted to be unresectable for cure. With the exception of three benign smooth muscle tumors, all tumors with one or more CT morphologic features indicative of a malignant neoplasm were malignant (n = 16). Three of four intraluminal masses were benign. In three cases of polypoid tumors smaller than 2 cm, a duodenal tumor was not seen on CT. Whenever extraduodenal disease was found (15 cases), the neoplasms were malignant. In the 22 cases in which a tumor was detected on CT, the sensitivity of using the presence of one or more morphologic features associated with a malignant neoplasm as a predictor was 94%; the specificity was 50%, and the accuracy was 82%. If the presence of any morphologic feature indicative of a malignant neoplasm was combined with the presence of any finding of extraduodenal disease, CT was 100% sensitive and 86% accurate for predicting that the tumor was malignant. CT appears to be reliable for predicting duodenal tumor resectability. On the basis of CT findings, 10 tumors were correctly predicted as being unresectable for cure, and 12 were predicted as being resectable; no surgery was performed in the remaining three cases. In conclusion, evaluation of the morphologic features of duodenal neoplasms is a sensitive, but nonspecific, method for predicting that a tumor is malignant.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1632344     DOI: 10.2214/ajr.159.2.1632344

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  19 in total

1.  Quiz case of the month. Villous tumor of the duodenum.

Authors:  O Rueda; C Alvarez; J M Vicente; J Martel; J Escribano
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

2.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-Liang Han; Jun Cheng; Hong-Zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2010-12

Review 3.  Upper gastrointestinal barium evaluation of duodenal pathology: A pictorial review.

Authors:  Pankaj Gupta; Uma Debi; Saroj Kant Sinha; Kaushal Kishor Prasad
Journal:  World J Radiol       Date:  2014-08-28

4.  Focus on the diagnostic problems of primary adenocarcinoma of the third and fourth portion of the duodenum. Case report.

Authors:  M Bandi; L Scagliarini; G Anania; M Pedriali; G Resta
Journal:  G Chir       Date:  2015 Jul-Aug

Review 5.  Malignant small-bowel neoplasms: spectrum of disease on MR imaging.

Authors:  F Crusco; F Pugliese; A Maselli; G Pelliccia; E Mariani; F Farroni; A Giovagnoni
Journal:  Radiol Med       Date:  2010-09-17       Impact factor: 3.469

6.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

7.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-liang Han; Jun Cheng; Hong-zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2009-06-10

8.  Carcinoma of the fourth part of the duodenum: report of a case.

Authors:  S Yildirim; A B Culhaoglu; N Ozdemir
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-Liang Han; Jun Cheng; Hong-Zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2009-04-28

Review 10.  Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Authors:  Jordan M Cloyd; Elizabeth George; Brendan C Visser
Journal:  World J Gastrointest Surg       Date:  2016-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.